Skip to content
10-K

Annual Report

PAR PHARMACEUTICAL COMPANIES, INC.

0000878088-14-000007

← back to feed
Filed
Mar 18, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Mar 18, 2014 100 sh
Net Income FY 2013 · Dec 31, 2013 −$105.87M
Long Term Debt FY 2013 · Dec 31, 2012 $1.53B
Short Term Debt FY 2013 · Dec 31, 2012 $10.55M
Cash And Equivalents FY 2013 · Dec 31, 2012 $36.79M
Stockholders Equity FY 2013 · Dec 31, 2012 $645.1M
Current Liabilities FY 2013 · Dec 31, 2012 $276.79M
Current Assets FY 2013 · Dec 31, 2012 $374.07M
Total Assets FY 2013 · Dec 31, 2012 $2.84B